We are live on ! Find out more
FNCH

Finch Therapeutics Group, Inc. Common Stock

Delisted

FNCH was delisted on the 24th of May, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$8.91M
AMC
2
Avenir Management Company
New York
$8.37M
BG
3
Baupost Group
Massachusetts
$5.65M -$70.4K -305 -0.8%
BL
4
Bleichroeder LP
New York
$4.08M
Vanguard Group
5
Vanguard Group
Pennsylvania
$3.99M -$20.3K -88 -0.3%
LSAG
6
Lake Street Advisors Group
New Hampshire
$3.72M
LSCM
7
Light Street Capital Management
California
$3.36M -$1.1M -4,766 -18%
TA
8
TRB Advisors
New York
$2.87M
BlackRock
9
BlackRock
New York
$2.04M +$70.4K +305 +2%
MP
10
MSD Partners
New York
$1.96M -$5.98M -25,913 -67%
IC
11
Ikarian Capital
Texas
$1.66M +$114K +493 +5%
AI
12
Aperture Investors
New York
$982K
Geode Capital Management
13
Geode Capital Management
Massachusetts
$806K +$71.3K +309 +6%
BP
14
Ballentine Partners
Massachusetts
$722K
PCP
15
Proficio Capital Partners
Massachusetts
$556K
State Street
16
State Street
Massachusetts
$549K +$22.8K +99 +3%
Northern Trust
17
Northern Trust
Illinois
$326K -$20.1K -87 -4%
Citadel Advisors
18
Citadel Advisors
Florida
$300K -$135K -586 -23%
LCM
19
Laurion Capital Management
New York
$292K
Charles Schwab
20
Charles Schwab
California
$277K -$21.2K -92 -5%
Renaissance Technologies
21
Renaissance Technologies
New York
$226K +$56.3K +244 +19%
SCM
22
SCS Capital Management
Massachusetts
$193K
Qube Research & Technologies (QRT)
23
Qube Research & Technologies (QRT)
United Kingdom
$189K +$101K +437 +53%
BFM
24
Boothbay Fund Management
New York
$161K
Morgan Stanley
25
Morgan Stanley
New York
$129K -$12.7K -55 -6%